Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus for Skin Cancer Prevention in Renal Transplant Recipients
NCT00866684Phase 4Terminated
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Jan 2007
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sirolimus in skin cancer (2 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Number of Events of Reoccurrence of Skin Cancer at 24 months. Started Jan 2007; status: terminated.
02
Drugs
sirolimus
03
Conditions
skin cancer
Beyond the preview
Go deeper on NCT00866684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00866684.